<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Risk factors and prevention of hospital-acquired and ventilator-associated pneumonia in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Klompas, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas M File, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 06, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hospital-acquired (or nosocomial) pneumonia (HAP) and ventilator-associated pneumonia (VAP) are important causes of morbidity and mortality despite improved antimicrobial therapy, supportive care, and prevention. The risk factors and prevention of HAP and VAP will be reviewed here.</p><p>The clinical presentation, diagnosis, epidemiology, pathogenesis, microbiology, and treatment of HAP and VAP are discussed separately. (See  <a class="medical medical_review" href="/d/html/1635.html" rel="external">"Clinical presentation and diagnostic evaluation of ventilator-associated pneumonia"</a> and  <a class="medical medical_review" href="/d/html/7020.html" rel="external">"Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired and ventilator-associated pneumonia in adults"</a> and  <a class="medical medical_review" href="/d/html/6993.html" rel="external">"Treatment of hospital-acquired and ventilator-associated pneumonia in adults"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">DEFINITIONS</span></p><p class="headingAnchor" id="H815918199"><span class="h2">Pneumonia types</span><span class="headingEndMark"> — </span>Pneumonia is frequently categorized based on site of acquisition  (<a class="graphic graphic_table graphicRef130821" href="/d/graphic/130821.html" rel="external">table 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hospital-acquired (or nosocomial) pneumonia (HAP)</strong> is pneumonia that occurs 48 hours or more after admission to the hospital and did not appear to be incubating at the time of admission. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ventilator-associated pneumonia (VAP)</strong> is a type of HAP that develops in intubated patients on mechanical ventilation for more than 48 hours. VAP also includes HAP that occurs within 48 hours of extubation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Non-ventilator-associated HAP (NV-HAP)</strong> refers to HAP that develops in hospitalized patients who are not on mechanical ventilation nor underwent extubation within 48 hours before pneumonia developed. NV-HAP can be divided into patients that ultimately require mechanical ventilation (VHAP) due to the pneumonia versus those that do not. VHAP is associated with particularly poor clinical outcomes. </p><p></p><p>The category of health care-associated pneumonia (HCAP) is no longer recognized as a separate category of pneumonia and was purposefully not included in the 2016 and 2019 American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA) HAP [<a href="#rid1">1</a>] and community-acquired pneumonia (CAP) [<a href="#rid2">2</a>] guidelines or the combined 2017 European and Latin American HAP guidelines [<a href="#rid3">3</a>]. Historically, HCAP referred to pneumonia acquired in health care facilities such as nursing homes, hemodialysis centers, and outpatient clinics, or pneumonia acquired within three months following a hospitalization [<a href="#rid4">4</a>]. This category was used to identify patients at risk for infection with multidrug-resistant (MDR) pathogens. However, this categorization may have been overly sensitive and may have led to increased, inappropriate broad antibiotic use. Although patients with recent contact with health care facilities are at increased risk for infection with MDR pathogens, this risk is small for most patients and the overall incidence of MDR pathogens in this population is low [<a href="#rid5">5-11</a>]. </p><p>We manage patients who would have been previously classified as having HCAP in a similar way to those with CAP, deciding whether to include therapy targeting MDR pathogens on a case-by-case basis depending upon each patient's specific risk factors and severity of illness [<a href="#rid2">2</a>]. Specific risk factors for resistance that should be assessed include known colonization with MDR pathogens, recent receipt of antimicrobials, comorbidities, functional status, and severity of illness [<a href="#rid12">12,13</a>]. (See  <a class="medical medical_review" href="/d/html/7031.html" rel="external">"Treatment of community-acquired pneumonia in adults in the outpatient setting"</a> and  <a class="medical medical_review" href="/d/html/7027.html" rel="external">"Treatment of community-acquired pneumonia in adults who require hospitalization"</a>.)</p><p class="headingAnchor" id="H2267263569"><span class="h2">Antimicrobial resistance</span><span class="headingEndMark"> — </span>The United States Centers for Disease Control and Prevention and the European Centre for Disease Prevention and Control have developed standard terminology for antimicrobial-resistant gram-negative bacilli, which are important causes of HAP and VAP [<a href="#rid14">14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>MDR refers to acquired nonsusceptibility to at least one agent in three different antimicrobial classes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Extensively drug resistant refers to nonsusceptibility to at least one agent in all but two antimicrobial classes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pandrug resistant refers to nonsusceptibility to all antimicrobial agents that can be used for treatment.</p><p></p><p>Awareness of local resistance patterns is critical for decisions regarding empiric therapy for HAP and VAP [<a href="#rid15">15</a>]. All hospitals should regularly create and disseminate a local antibiogram, ideally one that is specific to the different units in the hospital (although small numbers of cases per unit may preclude this) [<a href="#rid1">1</a>].</p><p class="headingAnchor" id="H3812962358"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>The most significant risk factor for HAP is intubation. Other risk factors, which have emerged from multivariate analyses, include [<a href="#rid16">16-30</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Older age [<a href="#rid22">22,31</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic lung disease [<a href="#rid19">19</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Depressed consciousness [<a href="#rid32">32</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Aspiration [<a href="#rid19">19</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Chest or upper abdominal surgery [<a href="#rid19">19,26,32</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Agents that increase gastric pH (H<sub>2</sub> blockers, antacids, proton pump inhibitors [PPIs]) (see <a class="local">'Role of gastric pH'</a> below)</p><p class="bulletIndent1"><span class="glyph">●</span>Previous antibiotic exposure, especially broad spectrum [<a href="#rid33">33,34</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Reintubation or prolonged intubation [<a href="#rid20">20,21,26,33,35,36</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Mechanical ventilation for acute respiratory distress syndrome [<a href="#rid24">24,37</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Frequent ventilator circuit changes (see  <a class="medical medical_review" href="/d/html/1656.html" rel="external">"The ventilator circuit"</a>)</p><p class="bulletIndent1"><span class="glyph">●</span>Total opioid exposure [<a href="#rid38">38</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple trauma [<a href="#rid33">33,35</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Paralysis [<a href="#rid35">35</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Number of central venous catheter placements and surgeries [<a href="#rid36">36</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Use of muscle relaxants or glucocorticoids [<a href="#rid36">36</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>The presence of an intracranial pressure monitor [<a href="#rid16">16</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Malnutrition, chronic renal failure, anemia, Charlson Comorbidity Index, previous hospitalization [<a href="#rid32">32</a>]</p><p></p><p class="headingAnchor" id="H6"><span class="h2">Role of gastric pH</span><span class="headingEndMark"> — </span>Several studies have noted an increased incidence of HAP when the gastric pH is increased with the use of H<sub>2</sub> blockers, antacids, or PPIs [<a href="#rid39">39-42</a>]. We avoid agents that raise gastric pH in patients who are not at high risk of developing a stress ulcer or stress gastritis.</p><p>Some meta-analyses have found decreased rates of pneumonia in critically ill patients using <a class="drug drug_general" data-topicid="9953" href="/d/drug information/9953.html" rel="external">sucralfate</a> for stress ulcer prophylaxis compared with H<sub>2</sub> blockers and PPIs [<a href="#rid40">40,43</a>]. In one meta-analysis of 21 randomized trials, for example, the incidence of pneumonia was lower in critically ill patients receiving sucralfate compared with those receiving H<sub>2</sub> blockers (relative risk [RR] 0.84, 95% CI 0.72-0.98) [<a href="#rid43">43</a>]. No difference in bleeding risk was detected. Similar findings were observed in a network meta-analysis of 57 trials evaluating 7293 critically ill patients receiving stress ulcer prophylaxis [<a href="#rid40">40</a>]. Both H<sub>2</sub> blockers and PPIs were associated with an increased risk of pneumonia when compared with sucralfate (odds ratio [OR] 1.30, 95% CI 1.08-1.58, and OR 1.65, 95% CI 1.20-2.27, respectively). Other meta-analyses, however, have not reported an association between stress ulcer prophylaxis and HAP, particularly when restricting the analysis to randomized trials at low risk of bias [<a href="#rid41">41</a>].</p><p>Similarly, a large randomized trial of PPIs versus placebo reported no impact on HAP [<a href="#rid44">44</a>]. In this study, 3298 intensive care unit (ICU) patients were randomized to daily <a class="drug drug_general" data-topicid="9474" href="/d/drug information/9474.html" rel="external">pantoprazole</a> versus placebo. There was no difference between groups in 90-day mortality nor in the composite outcome of gastrointestinal bleeding, pneumonia, <em>Clostridioides difficile</em> infection, or myocardial ischemia. Specifically, pneumonia rates were identical between groups.</p><p class="headingAnchor" id="H7"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>The Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) issue updated <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cambridge.org%2Fcore%2Fjournals%2Finfection-control-and-hospital-epidemiology%2Farticle%2Fstrategies-to-prevent-ventilatorassociated-pneumonia-ventilatorassociated-events-and-nonventilator-hospitalacquired-pneumonia-in-acutecare-hospitals-2022-update%2FA2124BA9B088027AE30BE46C28887084&amp;token=vbF7fpuMR9ji%2FlBgQQiAkWJfGiER8E8tp9jbIiVi2%2FEQXG6yW8K%2FLyTJ470Bs%2FpD5tun%2B2GXbbTgrtjleUki7%2F6mRhJeKejg1aj%2FQg5uHkIStkB79uM6pSgP5WqHJkClD63CJ9poKqNYeuRciW%2BifhO83QO3v2mKfetgcTGA0qMK8YqZMdz7tVo6UBS9ZngjnrkfelMpaL4%2Fo%2F3ZEOdrPmRllu1uDcHTc%2Fce%2FQdBQYrqn8A9U0Ro%2Bta%2Bne7dDHPa&amp;TOPIC_ID=6995" target="_blank">practice recommendations</a> to reduce the risk of VAP and NV-HAP  (<a class="graphic graphic_table graphicRef69916" href="/d/graphic/69916.html" rel="external">table 2</a>) [<a href="#rid45">45</a>]. Essential practices that are recommended by SHEA/IDSA for preventing VAP and NV-HAP in all acute care hospitals include avoiding intubation and preventing reintubation when possible (eg, using noninvasive ventilation or high-flow oxygen by nasal cannula instead), minimizing sedation through the use of sedative protocols, implementing ventilator liberation protocols, maintaining and improving physical conditioning, elevating the head of the bed, providing oral care with toothbrushing but without <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a>, and changing ventilator circuits only if visibly soiled or malfunctioning. Although evidence supporting the use of bundles is mixed, combining a core set of prevention measures into a bundle can be a practical way to enhance care [<a href="#rid46">46-53</a>]. (See <a class="local">'Prevention bundles'</a> below.)</p><p>The following discussion will review some of the modalities that have been evaluated for preventing VAP. The approach to mechanical ventilation, noninvasive ventilation, maintenance of the ventilator circuit, and sedation is discussed separately. (See  <a class="medical medical_review" href="/d/html/1640.html" rel="external">"Overview of initiating invasive mechanical ventilation in adults in the intensive care unit"</a> and  <a class="medical medical_review" href="/d/html/1644.html" rel="external">"Complications of the endotracheal tube following initial placement: Prevention and management in adult intensive care unit patients", section on 'Suctioning and oral care'</a> and  <a class="medical medical_review" href="/d/html/1656.html" rel="external">"The ventilator circuit"</a> and  <a class="medical medical_review" href="/d/html/1606.html" rel="external">"Sedative-analgesia in ventilated adults: Management strategies, agent selection, monitoring, and withdrawal"</a>.)</p><p>General issues related to prevention of infections in the intensive care unit (ICU) and infection control are discussed separately. (See  <a class="medical medical_review" href="/d/html/3810.html" rel="external">"Nosocomial infections in the intensive care unit: Epidemiology and prevention"</a> and  <a class="medical medical_review" href="/d/html/4042.html" rel="external">"Infection prevention: Precautions for preventing transmission of infection"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Preventing aspiration</span><span class="headingEndMark"> — </span>Aspiration is a major predisposing mechanism for both HAP and VAP. Elevating the head of the bed, minimizing sedation, draining subglottic secretions in ventilated patients, maintaining endotracheal tube airway cuff pressure (20 to 30 cm H<sub>2</sub>O), and application of positive end-expiratory pressure are measures that have been proposed to minimize aspiration [<a href="#rid54">54,55</a>]. (See  <a class="medical medical_review" href="/d/html/1644.html" rel="external">"Complications of the endotracheal tube following initial placement: Prevention and management in adult intensive care unit patients", section on 'Maintain optimal cuff pressure'</a> and  <a class="medical medical_review" href="/d/html/1642.html" rel="external">"Positive end-expiratory pressure (PEEP)"</a>.)</p><p class="headingAnchor" id="H12"><span class="h3">Patient positioning</span><span class="headingEndMark"> — </span>Supine positioning appears to predispose to aspiration and the development of HAP, particularly in patients receiving enteral nutrition [<a href="#rid53">53</a>]. The head of the bed should therefore be elevated to 30 to 45° [<a href="#rid46">46</a>]. In a meta-analysis of eight randomized trials evaluating over 750 mechanically ventilated adults, semirecumbent positioning (≥30 to 60°) appeared to reduce rates of clinically suspected VAP when compared with supine positioning but showed no impact on duration of mechanical ventilation, ICU length of stay, or mortality [<a href="#rid56">56</a>]. One randomized trial evaluated the impact of placing patients in the lateral Trendelenburg position in order to preferentially drain oral secretions away from the lungs [<a href="#rid57">57</a>]. VAP rates were lower in patients randomized to the lateral Trendelenburg position compared with the semirecumbent position (relative risk [RR] 0.13, 95% CI 0.02-1.03), but the trial was stopped early due to increased adverse events (eg, transient oxygen desaturation and hemodynamic instability) among patients placed in lateral Trendelenburg. While no effect of positioning on duration of mechanical ventilation or mortality has been demonstrated, it seems prudent to preferentially place intubated patients in the semirecumbent position unless contraindicated [<a href="#rid51">51,58</a>].</p><p class="headingAnchor" id="H13"><span class="h3">Subglottic drainage</span><span class="headingEndMark"> — </span>Drainage of subglottic secretions that pool above the endotracheal tube cuff may lessen the risk of aspiration of secretions around the cuff and thereby decrease the incidence of VAP. Specially designed endotracheal tubes have been developed to provide continuous or intermittent aspiration of subglottic secretions  (<a class="graphic graphic_figure graphicRef68552" href="/d/graphic/68552.html" rel="external">figure 1</a>) [<a href="#rid59">59-61</a>]. However, these devices cost more than standard endotracheal tubes and are not widely available. When available, they should be used for patients expected to require &gt;48 or 72 hours of mechanical ventilation [<a href="#rid46">46</a>]. In a meta-analysis of 20 randomized trials evaluating 3684 patients, subglottic secretion drainage reduced the risk of VAP from 23 to 14 percent (RR 0.56, 95% CI 0.48-0.63) [<a href="#rid62">62</a>]. The authors initially reported a significant decrease in mortality but subsequently published a correction that indicated no change in mortality [<a href="#rid63">63</a>]. There were no significant differences in duration of mechanical ventilation or ICU length of stay.</p><p class="headingAnchor" id="H4934851"><span class="h3">Gastric volume monitoring</span><span class="headingEndMark"> — </span>It has long been standard clinical practice to monitor patients’ gastric residual volume at regular intervals and/or prior to increasing the infusion rate of gastric tube feeding, with the hope of minimizing the risk of unrecognized gastric fluid accumulation and vomiting resulting in pneumonia. However, several studies have shown that measurement of gastric residuals correlates poorly with aspiration risk and is associated with a decrease in calorie delivery [<a href="#rid64">64-66</a>]. Furthermore, a randomized trial has shown that the rate of VAP was not higher in patients who did not undergo monitoring of gastric residuals [<a href="#rid67">67</a>]. Based on these findings, we do not routinely check gastric residual volumes in asymptomatic patients receiving tube feedings. This is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/1605.html" rel="external">"Nutrition support in intubated critically ill adult patients: Enteral nutrition", section on 'Monitoring and management of complications'</a>.)</p><p class="headingAnchor" id="H606026700"><span class="h2">Decontamination of the oropharynx and digestive tract</span><span class="headingEndMark"> — </span>Decontamination of the oropharynx and/or digestive tract may reduce the incidence of pneumonia in critically ill patients by decreasing colonization of the upper respiratory tract. Potential methods used include antiseptics (eg, <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a>) in the oropharynx, selective decontamination of the oropharyngeal tract (SOD) with nonabsorbable antibiotics applied in the oropharynx, and selective decontamination of the digestive tract (SDD) with nonabsorbable antibiotics applied to the oropharynx and administered orally, with or without intravenous antibiotics.</p><p class="headingAnchor" id="H42805921"><span class="h3">Chlorhexidine</span><span class="headingEndMark"> — </span>The SHEA/IDSA guidelines recommend daily oral care with toothbrushing but without <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> due to the lack of clear evidence that chlorhexidine reduces pulmonary infections and the possible increase in mortality [<a href="#rid45">45</a>]. </p><p><a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">Chlorhexidine</a> use is controversial because of its uncertain efficacy and possible association with increased mortality [<a href="#rid51">51,68-72</a>]. Several meta-analyses of randomized trials have reported an association between chlorhexidine and lower VAP rates [<a href="#rid68">68-70,72,73</a>]. One meta-analysis reported that oral care with chlorhexidine was associated with an RR for VAP of 0.67 (95% CI 0.47-0.97) based on review of 13 randomized trial including &gt;1200 patients [<a href="#rid73">73</a>]. However, this finding should be interpreted with caution because the diagnostic criteria used for VAP were subjective and nonspecific, and multiple open-label trials were included in the analysis, introducing risk of bias. </p><p>Another meta-analysis of 16 trials evaluating 3630 critically ill patients showed a strong trend toward decreased VAP rates among open-label trials (RR 0.61, 95% CI 0.35-1.04) but a much weaker effect amongst blinded trials (RR 0.88, 95% CI 0.66-1.16) [<a href="#rid72">72</a>]. None of the meta-analyses have found differences between <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> versus placebo in duration of mechanical ventilation, ICU length of stay, or hospital length of stay.</p><p>An increase in mortality with <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> use was detected in a single meta-analysis of 11 trials evaluating 2618 ICU patients when compared with placebo (28.5 versus 24.5 percent; odds ratio [OR] 1.25, 95% CI 1.05-1.50) [<a href="#rid70">70</a>]. In a subsequent retrospective review of 5539 mechanically ventilated patients, chlorhexidine was associated with an increased risk for ventilator mortality (hazard ratio [HR] 1.63, 95% CI 1.15-2.31) [<a href="#rid51">51</a>]. Other observational studies have raised the same concern [<a href="#rid74">74</a>]. The mechanism by which chlorhexidine might increase mortality is unclear. One hypothesis is that aspiration of chlorhexidine may precipitate acute respiratory distress syndrome in a small fraction of patients.</p><p>A cluster randomized trial of <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> discontinuation versus usual care conducted amongst 3260 patients in six ICUs in Canada reported that discontinuing chlorhexidine had no impact on infection-related ventilator-associated complications (a proxy for VAP, 4.8 versus 2.5 percent, OR 1.06, 95% CI 0.44-2.57), time to extubation (median 2 days versus 2 days, OR 1.03, 95% CI 0.83-1.23), or ICU mortality (23.5 versus 21.2 percent, OR 1.13, 95% CI 0.82-1.54) [<a href="#rid75">75</a>]. Oral health scores, however, were better amongst patients randomized to chlorhexidine de-adoption. De-adoption of chlorhexidine was accompanied by a multicomponent oral care bundle that included twice-daily oral assessment and toothbrushing, mouth moisturization, and lip moisturization with additional secretion removal every four hours. </p><p class="headingAnchor" id="H1487977197"><span class="h3">Selective decontamination of the digestive tract</span><span class="headingEndMark"> — </span>Selective decontamination of the digestive tract (SDD) refers to use of nonabsorbable antibiotics applied to the oropharynx and administered orally, with or without four days of intravenous antibiotics. Examples of antimicrobials included in oral and gastric tube regimens include <a class="drug drug_general" data-topicid="8718" href="/d/drug information/8718.html" rel="external">colistin</a>, <a class="drug drug_general" data-topicid="10000" href="/d/drug information/10000.html" rel="external">tobramycin</a>, and <a class="drug drug_general" data-topicid="9712" href="/d/drug information/9712.html" rel="external">nystatin</a>. The intravenous agent is typically a third-generation cephalosporin or a quinolone.</p><p>Meta-analyses have shown that SDD reduces the risk of VAP and HAP [<a href="#rid76">76-79</a>], particularly when the SDD regimen includes an intravenous component [<a href="#rid80">80</a>]. Both SOD and SDD have shown mortality benefits in trials of ICU patients performed mainly in regions with low baseline antimicrobial resistance rates [<a href="#rid81">81,82</a>]. The applicability of the studies showing benefit to other settings has been questioned since very low rates of antibiotic resistance were present at the institutions included in the key trials [<a href="#rid83">83,84</a>].</p><p>In a multicenter randomized trial performed in European ICUs with high baseline antimicrobial resistance rates, no difference in 28-day mortality was detected with SOD, SDD, or 1% <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> oral care when compared with standard practice [<a href="#rid85">85</a>]. Because standard practice included oral care with 0.12 or 0.20% in most centers, the effect of chlorhexidine versus placebo on mortality could not be determined from this trial. The effect of these interventions on VAP was not reported. Of note, the SDD regimen in this trial did not include an intravenous component.</p><p>Because of the potential for promoting antimicrobial resistance with widespread SDD use, the practice has not been routinely adopted in North America [<a href="#rid4">4,46,84,86,87</a>]; the Society for Healthcare Epidemiology of America guidelines and combined European and Latin American HAP and VAP guidelines recommend against SDD [<a href="#rid3">3,45</a>] in settings with high baseline rates of antimicrobial utilization and antimicrobial resistance.</p><p>Additional detail on SDD is discussed separately. (See  <a class="medical medical_review" href="/d/html/3810.html" rel="external">"Nosocomial infections in the intensive care unit: Epidemiology and prevention", section on 'Digestive and oropharyngeal decontamination'</a>.)</p><p class="headingAnchor" id="H606026706"><span class="h2">Probiotics</span><span class="headingEndMark"> — </span>Probiotics are defined as live microorganisms of human origin that are able to tolerate the hostile gastrointestinal environment such that they persist in the lower alimentary tract to confer a health benefit to the host [<a href="#rid88">88,89</a>]. Available results do not provide sufficient evidence to draw conclusions regarding the efficacy or safety of probiotics for the prevention of VAP. Therefore, we do not use probiotics for the prevention of VAP.</p><p>In a meta-analysis of 13 randomized trials comparing a probiotic (eg, <a class="drug drug_general" data-topicid="9541" href="/d/drug information/9541.html" rel="external">Lactobacillus</a> spp) with a control, probiotic use was associated with reduced incidence of VAP (OR 0.62, 95% CI 0.45-0.85) [<a href="#rid90">90</a>]. However, when the meta-analysis was limited to the six trials that were double-blinded, the reduction in VAP incidence did not reach statistical significance. A subsequent multicenter randomized controlled trial of 2650 patients in the ICU randomized patients to <em>Lactobacillus rhamnosus</em> probiotic twice daily versus placebo and found a similar incidence of VAP in both groups (21.9 versus 21.3 percent) [<a href="#rid91">91</a>]. Twelve patients in the probiotic group with adverse events had the probiotic <em>Lactobacillus</em> strain isolated from a sterile body site. An updated meta-analysis that included this trial and focused on studies with low risk of bias also reported no association between probiotics and VAP, HAP, or hospital length of stay [<a href="#rid92">92</a>].</p><p class="headingAnchor" id="H14"><span class="h2">Silver-coated endotracheal tube</span><span class="headingEndMark"> — </span>We do not use silver-coated endotracheal tubes (ETTs). Silver-coated ETTs may reduce the incidence of VAP but have no clear impact on other important outcomes [<a href="#rid93">93,94</a>]. This was illustrated in a randomized single-blinded trial (NASCENT) in which a silver-coated ETT was compared with an uncoated ETT in 2003 patients requiring mechanical ventilation [<a href="#rid93">93</a>]. Among patients intubated for more than 24 hours, the rate of microbiologically confirmed VAP was significantly lower with the silver-coated ETT (4.8 versus 7.5 percent). The silver-coated ETT was also associated with a significant delay in the occurrence of VAP. There were no differences between groups, however, in the duration of intubation, ICU stay, or hospital stay; mortality; or the frequency or severity of adverse events.</p><p class="headingAnchor" id="H1520896130"><span class="h2">Inhaled antibiotics</span><span class="headingEndMark"> — </span>The efficacy of inhaled antibiotics for the prevention of VAP is uncertain. In a meta-analysis of over 1000 patients on mechanical ventilation, receipt of inhaled antibiotics reduced occurrence of VAP compared with placebo (RR 0.7, 95% CI 0.59-0.82) but did not reduce mortality [<a href="#rid95">95</a>]. In another double-blinded randomized study of 850 patients on mechanical ventilation for 72 to 96 hours, receipt of daily inhaled <a class="drug drug_general" data-topicid="8536" href="/d/drug information/8536.html" rel="external">amikacin</a> for the next three days reduced the incidence of VAP within the next 28 days compared with placebo (15 versus 22 percent, p = 0.004) [<a href="#rid96">96</a>]. However, there was no difference detected in duration of mechanical ventilation, days of antibiotic utilization, or mortality between the two groups as would be expected if incidence of VAP decreased with the intervention. Additionally, there remains concern that widespread use of prophylactic inhaled amikacin may select for colonization with multidrug resistant bacteria.</p><p class="headingAnchor" id="H76306450"><span class="h2">Prevention bundles</span><span class="headingEndMark"> — </span>VAP prevention bundles involve the integrated implementation of a combination of measures aimed at reducing the incidence of VAP among patients at risk. Bundling multiple measures together is hypothesized to provide synergistic protection against HAP or VAP. Typical bundle components include educational programs, technical measures, surveillance, and feedback [<a href="#rid97">97</a>]. Developing VAP prevention bundles is a practical way to enhance care. However, there is no consensus about which care processes to include in bundles [<a href="#rid46">46,98</a>].</p><p>Accurately assessing the impact of VAP bundles is challenging because of the subjectivity and lack of specificity of VAP diagnostic criteria. For example, it is difficult to determine whether observed decreases in VAP incidence represent true declines or stricter application of subjective criteria. This is of particular concern because hospitals and quality improvement advocates have an interest in being able to report lower VAP rates, and bundle implementations by nature are implemented in an open-label fashion.</p><p>Examples of studies that evaluated VAP prevention bundles include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective surveillance study conducted in 181 Spanish ICUs (the Pneumonia Zero project), VAP incidence declined from 9.8 to 4.3 episodes per 1000 ventilator days with institution of a prevention bundle that included seven mandatory measures including education and training in airway management, strict hand hygiene before airway management, control and maintenance of cuff pressure, oral care with <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a>, semirecumbent positioning, protocols for minimizing sedation, and avoiding elective changes of ventilator circuits, humidifiers, and endotracheal tubes [<a href="#rid99">99</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another cohort study, VAP incidence declined from 23 to 13 episodes per 1000 ventilator days with the institution of a bundle that contained hand hygiene, glove and gown compliance, elevation of the head of the bed, oral care with <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a>, maintaining an endotracheal tube cuff pressure &gt;20 cm H<sub>2</sub>0, orogastric rather than nasogastric feeding tubes, avoiding gastric overdistention, and eliminating nonessential tracheal suctioning [<a href="#rid97">97</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a multicenter cohort study, VAP incidence declined from 5.5 to 0 cases per 1000 ventilator days across 110 ICUs with institution of a bundle that included semirecumbent positioning, minimization of sedation, daily assessments for extubation, stress ulcer prophylaxis, and deep vein thrombosis prophylaxis [<a href="#rid100">100</a>].</p><p></p><p>One retrospective cohort study sought to determine which components of VAP prevention bundles are efficacious [<a href="#rid51">51</a>]. In evaluation of 5539 mechanically ventilated patients, the following interventions were found to be beneficial: semirecumbent positioning, sedation interruptions, spontaneous breathing trials, and deep vein thrombosis prophylaxis. By contrast, stress ulcer prophylaxis was associated with an increased risk of VAP (HR 7.69, 95% CI 1.44-41.1), and oral <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> was associated with increased mortality (HR 1.63, 95% CI 1.15-2.31). While the latter association is concerning, whether chlorhexidine is a causal factor is not clear. (See <a class="local">'Decontamination of the oropharynx and digestive tract'</a> above.)</p><p>A meta-analysis of 13 observational studies evaluating the effect of VAP bundles on mortality reported a 10 percent decrease in mortality following bundle implementation (OR 0.90, 95% CI 0.84-0.97) [<a href="#rid101">101</a>]. These results should be interpreted with caution, however, due to the observational nature of the included studies, variations in bundle components, and lack of correlation between bundle adherence rates and mortality.</p><p class="headingAnchor" id="H3627332861"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109779.html" rel="external">"Society guideline links: Hospital-acquired pneumonia and ventilator-associated pneumonia in adults"</a>.)</p><p class="headingAnchor" id="H9524225"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83154.html" rel="external">"Patient education: Hospital-acquired pneumonia (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H15"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definitions </strong>–<strong> </strong>The following types of nosocomial pneumonia have been defined  (<a class="graphic graphic_table graphicRef130821" href="/d/graphic/130821.html" rel="external">table 1</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hospital-acquired (or nosocomial) pneumonia (HAP) is pneumonia that occurs 48 hours or more after admission to the hospital and did not appear to be incubating at the time of admission. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ventilator-associated pneumonia (VAP) is a type of HAP that develops in intubated patients on mechanical ventilation for more than 48 hours. VAP also includes HAP that occurs within 48 hours of extubation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Non-ventilator-associated HAP (NV-HAP) refers to HAP that develops in hospitalized patients who are not on mechanical ventilation nor underwent extubation within 48 hours before pneumonia developed. NV-HAP can be divided into patients that ultimately require mechanical ventilation (VHAP) due to the pneumonia versus those that do not. VHAP is associated with particularly poor clinical outcomes. (See <a class="local">'Pneumonia types'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors </strong>–<strong> </strong>The most significant risk factor for HAP is intubation for mechanical ventilation; other risk factors include older age, chronic lung disease, depressed consciousness, and aspiration, among others. (See <a class="local">'Risk factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention practices </strong>–<strong> </strong>Practices that are recommended for preventing VAP include avoiding intubation when possible, minimizing sedation, instituting ventilator liberation protocols, maintaining and improving physical conditioning, providing regular oral care with toothbrushing, elevating the head of the bed, and changing ventilator circuits only when visibly soiled or damaged  (<a class="graphic graphic_table graphicRef69916" href="/d/graphic/69916.html" rel="external">table 2</a>). Although evidence supporting VAP prevention bundles is heterogenous, combining a core set of prevention measures into a bundle is a practical way to enhance care. (See <a class="local">'Prevention'</a> above.)</p><p></p><p class="headingAnchor" id="H1965926125"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>UpToDate gratefully acknowledges John G Bartlett, MD (deceased), who contributed on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Infectious Diseases.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kalil AC, Metersky ML, Klompas M, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63:e61.</a></li><li><a class="nounderline abstract_t">Metlay JP, Waterer GW, Long AC, et al. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019; 200:e45.</a></li><li><a class="nounderline abstract_t">Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J 2017; 50.</a></li><li><a class="nounderline abstract_t">American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388.</a></li><li><a class="nounderline abstract_t">Kollef MH. Health care-associated pneumonia: perception versus reality. Clin Infect Dis 2009; 49:1875.</a></li><li><a class="nounderline abstract_t">Murri R, De Pascale G. The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal? Clin Infect Dis 2012; 54:199.</a></li><li><a class="nounderline abstract_t">Ewig S, Welte T, Torres A. Is healthcare-associated pneumonia a distinct entity needing specific therapy? Curr Opin Infect Dis 2012; 25:166.</a></li><li><a class="nounderline abstract_t">Chalmers JD, Taylor JK, Singanayagam A, et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011; 53:107.</a></li><li><a class="nounderline abstract_t">Yap V, Datta D, Metersky ML. Is the present definition of health care-associated pneumonia the best way to define risk of infection with antibiotic-resistant pathogens? Infect Dis Clin North Am 2013; 27:1.</a></li><li><a class="nounderline abstract_t">Ma HM, Wah JL, Woo J. Should nursing home-acquired pneumonia be treated as nosocomial pneumonia? J Am Med Dir Assoc 2012; 13:727.</a></li><li><a class="nounderline abstract_t">Chalmers JD, Rother C, Salih W, Ewig S. Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis. Clin Infect Dis 2014; 58:330.</a></li><li><a class="nounderline abstract_t">Shorr AF, Zilberberg MD, Reichley R, et al. Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis 2012; 54:193.</a></li><li><a class="nounderline abstract_t">Webb BJ, Dascomb K, Stenehjem E, et al. Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score. Antimicrob Agents Chemother 2016; 60:2652.</a></li><li><a class="nounderline abstract_t">Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268.</a></li><li><a class="nounderline abstract_t">Beardsley JR, Williamson JC, Johnson JW, et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 2006; 130:787.</a></li><li><a class="nounderline abstract_t">Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133:792.</a></li><li><a class="nounderline abstract_t">Kollef MH. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit Care Med 2004; 32:1396.</a></li><li><a class="nounderline abstract_t">Bornstain C, Azoulay E, De Lassence A, et al. Sedation, sucralfate, and antibiotic use are potential means for protection against early-onset ventilator-associated pneumonia. Clin Infect Dis 2004; 38:1401.</a></li><li><a class="nounderline abstract_t">Celis R, Torres A, Gatell JM, et al. Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest 1988; 93:318.</a></li><li><a class="nounderline abstract_t">Kollef MH, Von Harz B, Prentice D, et al. Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. Chest 1997; 112:765.</a></li><li><a class="nounderline abstract_t">Torres A, Gatell JM, Aznar E, et al. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation. Am J Respir Crit Care Med 1995; 152:137.</a></li><li><a class="nounderline abstract_t">Kollef MH. Ventilator-associated pneumonia. A multivariate analysis. JAMA 1993; 270:1965.</a></li><li><a class="nounderline abstract_t">Kollef MH, Vlasnik J, Sharpless L, et al. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:1040.</a></li><li><a class="nounderline abstract_t">Chastre J, Trouillet JL, Vuagnat A, et al. Nosocomial pneumonia in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157:1165.</a></li><li><a class="nounderline abstract_t">Coffin SE, Klompas M, Classen D, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol 2008; 29 Suppl 1:S31.</a></li><li><a class="nounderline abstract_t">Hortal J, Giannella M, Pérez MJ, et al. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med 2009; 35:1518.</a></li><li><a class="nounderline abstract_t">Lukasewicz Ferreira SA, Hubner Dalmora C, Anziliero F, et al. Factors predicting non-ventilated hospital-acquired pneumonia: systematic review and meta-analysis. J Hosp Infect 2022; 119:64.</a></li><li><a class="nounderline abstract_t">Bergin SP, Coles A, Calvert SB, et al. PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the ICU. Chest 2020; 158:2370.</a></li><li><a class="nounderline abstract_t">Dananché C, Vanhems P, Machut A, et al. Trends of Incidence and Risk Factors of Ventilator-Associated Pneumonia in Elderly Patients Admitted to French ICUs Between 2007 and 2014. Crit Care Med 2018; 46:869.</a></li><li><a class="nounderline abstract_t">van der Kooi TII, Boshuizen H, Wille JC, et al. Using flexible methods to determine risk factors for ventilator-associated pneumonia in the Netherlands. PLoS One 2019; 14:e0218372.</a></li><li><a class="nounderline abstract_t">Tejerina E, Frutos-Vivar F, Restrepo MI, et al. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J Crit Care 2006; 21:56.</a></li><li><a class="nounderline abstract_t">Sopena N, Heras E, Casas I, et al. Risk factors for hospital-acquired pneumonia outside the intensive care unit: a case-control study. Am J Infect Control 2014; 42:38.</a></li><li><a class="nounderline abstract_t">Ranjan N, Chaudhary U, Chaudhry D, Ranjan KP. Ventilator-associated pneumonia in a tertiary care intensive care unit: Analysis of incidence, risk factors and mortality. Indian J Crit Care Med 2014; 18:200.</a></li><li><a class="nounderline abstract_t">Charles MP, Kali A, Easow JM, et al. Ventilator-associated pneumonia. Australas Med J 2014; 7:334.</a></li><li><a class="nounderline abstract_t">Wałaszek M, Kosiarska A, Gniadek A, et al. The risk factors for hospital-acquired pneumonia in the Intensive Care Unit. Przegl Epidemiol 2016; 70:15.</a></li><li><a class="nounderline abstract_t">Nakaviroj S, Cherdrungsi R, Chaiwat O. Incidence and risk factors for ventilator-associated pneumonia in the surgical intensive care unit, Siriraj Hospital. J Med Assoc Thai 2014; 97 Suppl 1:S61.</a></li><li><a class="nounderline abstract_t">Markowicz P, Wolff M, Djedaïni K, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med 2000; 161:1942.</a></li><li><a class="nounderline abstract_t">Lewis SC, Li L, Murphy MV, et al. Risk factors for ventilator-associated events: a case-control multivariable analysis. Crit Care Med 2014; 42:1839.</a></li><li><a class="nounderline abstract_t">Huang HB, Jiang W, Wang CY, et al. Stress ulcer prophylaxis in intensive care unit patients receiving enteral nutrition: a systematic review and meta-analysis. Crit Care 2018; 22:20.</a></li><li><a class="nounderline abstract_t">Alhazzani W, Alshamsi F, Belley-Cote E, et al. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med 2018; 44:1.</a></li><li><a class="nounderline abstract_t">Barbateskovic M, Marker S, Granholm A, et al. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 2019; 45:143.</a></li><li><a class="nounderline abstract_t">Sasabuchi Y, Matsui H, Lefor AK, et al. Risks and Benefits of Stress Ulcer Prophylaxis for Patients With Severe Sepsis. Crit Care Med 2016; 44:e464.</a></li><li><a class="nounderline abstract_t">Alquraini M, Alshamsi F, Møller MH, et al. Sucralfate versus histamine 2 receptor antagonists for stress ulcer prophylaxis in adult critically ill patients: A meta-analysis and trial sequential analysis of randomized trials. J Crit Care 2017; 40:21.</a></li><li><a class="nounderline abstract_t">Krag M, Marker S, Perner A, et al. Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. N Engl J Med 2018; 379:2199.</a></li><li><a class="nounderline abstract_t">Klompas M, Branson R, Cawcutt K, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol 2022; 43:687.</a></li><li><a class="nounderline abstract_t">Klompas M, Branson R, Eichenwald EC, et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35:915.</a></li><li><a class="nounderline abstract_t">Okgün Alcan A, Demir Korkmaz F, Uyar M. Prevention of ventilator-associated pneumonia: Use of the care bundle approach. Am J Infect Control 2016; 44:e173.</a></li><li><a class="nounderline abstract_t">DeLuca LA Jr, Walsh P, Davidson DD Jr, et al. Impact and feasibility of an emergency department-based ventilator-associated pneumonia bundle for patients intubated in an academic emergency department. Am J Infect Control 2017; 45:151.</a></li><li><a class="nounderline abstract_t">Khan R, Al-Dorzi HM, Al-Attas K, et al. The impact of implementing multifaceted interventions on the prevention of ventilator-associated pneumonia. Am J Infect Control 2016; 44:320.</a></li><li><a class="nounderline abstract_t">Marini AL, Khan R, Mundekkadan S. Multifaceted bundle interventions shown effective in reducing VAP rates in our multidisciplinary ICUs. BMJ Qual Improv Rep 2016; 5.</a></li><li><a class="nounderline abstract_t">Klompas M, Li L, Kleinman K, et al. Associations Between Ventilator Bundle Components and Outcomes. JAMA Intern Med 2016; 176:1277.</a></li><li><a class="nounderline abstract_t">Metersky ML, Wang Y, Klompas M, et al. Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013. JAMA 2016; 316:2427.</a></li><li><a class="nounderline abstract_t">Writing Group for the CHECKLIST-ICU Investigators and the Brazilian Research in Intensive Care Network (BRICNet), Cavalcanti AB, Bozza FA, et al. Effect of a Quality Improvement Intervention With Daily Round Checklists, Goal Setting, and Clinician Prompting on Mortality of Critically Ill Patients: A Randomized Clinical Trial. JAMA 2016; 315:1480.</a></li><li><a class="nounderline abstract_t">Manzano F, Fernández-Mondéjar E, Colmenero M, et al. Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in nonhypoxemic patients. Crit Care Med 2008; 36:2225.</a></li><li><a class="nounderline abstract_t">Lucangelo U, Zin WA, Antonaglia V, et al. Effect of positive expiratory pressure and type of tracheal cuff on the incidence of aspiration in mechanically ventilated patients in an intensive care unit. Crit Care Med 2008; 36:409.</a></li><li><a class="nounderline abstract_t">Wang L, Li X, Yang Z, et al. Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation. Cochrane Database Syst Rev 2016; 2016:CD009946.</a></li><li><a class="nounderline abstract_t">Li Bassi G, Panigada M, Ranzani OT, et al. Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia. Intensive Care Med 2017; 43:1572.</a></li><li><a class="nounderline abstract_t">Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354:1851.</a></li><li><a class="nounderline abstract_t">Torres A, Serra-Batlles J, Ros E, et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992; 116:540.</a></li><li><a class="nounderline abstract_t">Smulders K, van der Hoeven H, Weers-Pothoff I, Vandenbroucke-Grauls C. A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation. Chest 2002; 121:858.</a></li><li><a class="nounderline abstract_t">Kollef MH, Skubas NJ, Sundt TM. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. Chest 1999; 116:1339.</a></li><li><a class="nounderline abstract_t">"Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis". Diana P. Pozuelo-Carrascosa, Ángel Herráiz-Adillo, Celia Alvarez-Bueno, Jose Manuel Añón, Vicente Martínez-Vizcaíno and Iván Cavero-Redondo. Eur Respir Rev 2020; 29: 190107. Eur Respir Rev 2022; 31.</a></li><li><a class="nounderline abstract_t">Pozuelo-Carrascosa DP, Klompas M, Alvarez-Bueno C, et al. Correction to subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis. Eur Respir Rev 2022; 31.</a></li><li><a class="nounderline abstract_t">Mentec H, Dupont H, Bocchetti M, et al. Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications. Crit Care Med 2001; 29:1955.</a></li><li><a class="nounderline abstract_t">McClave SA, Lukan JK, Stefater JA, et al. Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients. Crit Care Med 2005; 33:324.</a></li><li><a class="nounderline abstract_t">Montejo JC, Miñambres E, Bordejé L, et al. Gastric residual volume during enteral nutrition in ICU patients: the REGANE study. Intensive Care Med 2010; 36:1386.</a></li><li><a class="nounderline abstract_t">Reignier J, Mercier E, Le Gouge A, et al. Effect of not monitoring residual gastric volume on risk of ventilator-associated pneumonia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial. JAMA 2013; 309:249.</a></li><li><a class="nounderline abstract_t">Chan EY, Ruest A, Meade MO, Cook DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ 2007; 334:889.</a></li><li><a class="nounderline abstract_t">Labeau SO, Van de Vyver K, Brusselaers N, et al. Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis. Lancet Infect Dis 2011; 11:845.</a></li><li><a class="nounderline abstract_t">Price R, MacLennan G, Glen J, SuDDICU Collaboration. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ 2014; 348:g2197.</a></li><li><a class="nounderline abstract_t">Hua F, Xie H, Worthington HV, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 2016; 10:CD008367.</a></li><li><a class="nounderline abstract_t">Klompas M, Speck K, Howell MD, et al. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 2014; 174:751.</a></li><li><a class="nounderline abstract_t">Zhao T, Wu X, Zhang Q, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 2020; 12:CD008367.</a></li><li><a class="nounderline abstract_t">Deschepper M, Waegeman W, Eeckloo K, et al. Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study. Intensive Care Med 2018; 44:1017.</a></li><li><a class="nounderline abstract_t">Dale CM, Rose L, Carbone S, et al. Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial. Intensive Care Med 2021; 47:1295.</a></li><li><a class="nounderline abstract_t">D'Amico R, Pifferi S, Leonetti C, et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998; 316:1275.</a></li><li><a class="nounderline abstract_t">Silvestri L, van Saene HK, Casarin A, et al. Impact of selective decontamination of the digestive tract on carriage and infection due to Gram-negative and Gram-positive bacteria: a systematic review of randomised controlled trials. Anaesth Intensive Care 2008; 36:324.</a></li><li><a class="nounderline abstract_t">Roquilly A, Marret E, Abraham E, Asehnoune K. Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis. Clin Infect Dis 2015; 60:64.</a></li><li><a class="nounderline abstract_t">Minozzi S, Pifferi S, Brazzi L, et al. Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation. Cochrane Database Syst Rev 2021; 1:CD000022.</a></li><li><a class="nounderline abstract_t">Hammond NE, Myburgh J, Seppelt I, et al. Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis. JAMA 2022; 328:1922.</a></li><li><a class="nounderline abstract_t">de Smet AM, Kluytmans JA, Cooper BS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360:20.</a></li><li><a class="nounderline abstract_t">Oostdijk EAN, Kesecioglu J, Schultz MJ, et al. Notice of Retraction and Replacement: Oostdijk et al. Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial. JAMA. 2014;312(14):1429-1437. JAMA 2017; 317:1583.</a></li><li><a class="nounderline abstract_t">Bonten MJ. Healthcare epidemiology: Ventilator-associated pneumonia: preventing the inevitable. Clin Infect Dis 2011; 52:115.</a></li><li><a class="nounderline abstract_t">Kollef MH, Micek ST. Rational use of antibiotics in the ICU: balancing stewardship and clinical outcomes. JAMA 2014; 312:1403.</a></li><li><a class="nounderline abstract_t">Wittekamp BH, Plantinga NL, Cooper BS, et al. Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial. JAMA 2018; 320:2087.</a></li><li><a class="nounderline abstract_t">Wunderink RG. Welkommen to our world. Emergence of antibiotic resistance with selective decontamination of the digestive tract. Am J Respir Crit Care Med 2010; 181:426.</a></li><li><a class="nounderline abstract_t">Oostdijk EA, de Smet AM, Blok HE, et al. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care Med 2010; 181:452.</a></li><li class="breakAll">Food and Agriculture Organization of the United Nations and World Health Organization. Guidelines for the evaluation of probiotics in food. http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdf (Accessed on January 10, 2011).</li><li><a class="nounderline abstract_t">Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182:1058.</a></li><li><a class="nounderline abstract_t">Su M, Jia Y, Li Y, et al. Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-Analysis of Randomized Controlled Trials. Respir Care 2020; 65:673.</a></li><li><a class="nounderline abstract_t">Johnstone J, Meade M, Lauzier F, et al. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial. JAMA 2021; 326:1024.</a></li><li><a class="nounderline abstract_t">Sharif S, Greer A, Skorupski C, et al. Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Crit Care Med 2022; 50:1175.</a></li><li><a class="nounderline abstract_t">Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008; 300:805.</a></li><li><a class="nounderline abstract_t">Tokmaji G, Vermeulen H, Müller MC, et al. Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients. Cochrane Database Syst Rev 2015; :CD009201.</a></li><li><a class="nounderline abstract_t">Zha S, Niu J, He Z, et al. Prophylactic antibiotics for preventing ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis. Eur J Med Res 2023; 28:348.</a></li><li><a class="nounderline abstract_t">Ehrmann S, Barbier F, Demiselle J, et al. Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia. N Engl J Med 2023; 389:2052.</a></li><li><a class="nounderline abstract_t">Bouadma L, Deslandes E, Lolom I, et al. Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis 2010; 51:1115.</a></li><li><a class="nounderline abstract_t">Klompas M. What is new in the prevention of nosocomial pneumonia in the ICU? Curr Opin Crit Care 2017; 23:378.</a></li><li><a class="nounderline abstract_t">Álvarez-Lerma F, Palomar-Martínez M, Sánchez-García M, et al. Prevention of Ventilator-Associated Pneumonia: The Multimodal Approach of the Spanish ICU "Pneumonia Zero" Program. Crit Care Med 2018; 46:181.</a></li><li><a class="nounderline abstract_t">Berenholtz SM, Pham JC, Thompson DA, et al. Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit. Infect Control Hosp Epidemiol 2011; 32:305.</a></li><li><a class="nounderline abstract_t">Pileggi C, Mascaro V, Bianco A, et al. Ventilator Bundle and Its Effects on Mortality Among ICU Patients: A Meta-Analysis. Crit Care Med 2018; 46:1167.</a></li></ol></div><div id="topicVersionRevision">Topic 6995 Version 49.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27418577" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31573350" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28890434" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15699079" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19911939" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Health care-associated pneumonia: perception versus reality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22109953" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The challenge of identifying resistant-organism pneumonia in the emergency department: still navigating on the erie canal?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22248977" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Is healthcare-associated pneumonia a distinct entity needing specific therapy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21690616" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23398862" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Is the present definition of health care-associated pneumonia the best way to define risk of infection with antibiotic-resistant pathogens?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22889729" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Should nursing home-acquired pneumonia be treated as nosocomial pneumonia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24270053" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22109951" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26856838" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21793988" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16963676" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3706887" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15187525" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Prevention of hospital-associated pneumonia and ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15156478" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Sedation, sucralfate, and antibiotic use are potential means for protection against early-onset ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3338299" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Nosocomial pneumonia. A multivariate analysis of risk and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9315813" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7599812" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8411554" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Ventilator-associated pneumonia. A multivariate analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9351601" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9563735" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Nosocomial pneumonia in patients with acute respiratory distress syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18840087" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Strategies to prevent ventilator-associated pneumonia in acute care hospitals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19557389" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Incidence and risk factors for ventilator-associated pneumonia after major heart surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34666117" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Factors predicting non-ventilated hospital-acquired pneumonia: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32615191" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the ICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29432348" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Trends of Incidence and Risk Factors of Ventilator-Associated Pneumonia in Elderly Patients Admitted to French ICUs Between 2007 and 2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31220122" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Using flexible methods to determine risk factors for ventilator-associated pneumonia in the Netherlands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16616625" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Incidence, risk factors, and outcome of ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24199911" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Risk factors for hospital-acquired pneumonia outside the intensive care unit: a case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24872648" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Ventilator-associated pneumonia in a tertiary care intensive care unit: Analysis of incidence, risk factors and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25279009" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27344468" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The risk factors for hospital-acquired pneumonia in the Intensive Care Unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24855844" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Incidence and risk factors for ventilator-associated pneumonia in the surgical intensive care unit, Siriraj Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10852771" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24751498" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Risk factors for ventilator-associated events: a case-control multivariable analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29374489" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Stress ulcer prophylaxis in intensive care unit patients receiving enteral nutrition: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29199388" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30680444" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27002276" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Risks and Benefits of Stress Ulcer Prophylaxis for Patients With Severe Sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28315586" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Sucralfate versus histamine 2 receptor antagonists for stress ulcer prophylaxis in adult critically ill patients: A meta-analysis and trial sequential analysis of randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30354950" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35589091" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25026607" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Strategies to prevent ventilator-associated pneumonia in acute care hospitals: 2014 update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27388264" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prevention of ventilator-associated pneumonia: Use of the care bundle approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27665031" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Impact and feasibility of an emergency department-based ventilator-associated pneumonia bundle for patients intubated in an academic emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26940595" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : The impact of implementing multifaceted interventions on the prevention of ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27096090" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Multifaceted bundle interventions shown effective in reducing VAP rates in our multidisciplinary ICUs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27428482" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Associations Between Ventilator Bundle Components and Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27835709" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27115264" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Effect of a Quality Improvement Intervention With Daily Round Checklists, Goal Setting, and Clinician Prompting on Mortality of Critically Ill Patients: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18664777" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in nonhypoxemic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18007268" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Effect of positive expiratory pressure and type of tracheal cuff on the incidence of aspiration in mechanically ventilated patients in an intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26743945" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Semi-recumbent position versus supine position for the prevention of ventilator-associated pneumonia in adults requiring mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29149418" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Randomized, multicenter trial of lateral Trendelenburg versus semirecumbent body position for the prevention of ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10584721" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1543307" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11888973" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A randomized clinical trial of intermittent subglottic secretion drainage in patients receiving mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10559097" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35321934" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : "Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis". Diana P. Pozuelo-Carrascosa,Ángel Herráiz-Adillo, Celia Alvarez-Bueno, Jose Manuel Añón, Vicente Martínez-Vizcaíno and Iván Cavero-Redondo. Eur Respir Rev 2020; 29: 190107.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35321932" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Correction to subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11588461" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Upper digestive intolerance during enteral nutrition in critically ill patients: frequency, risk factors, and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15699835" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20232036" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Gastric residual volume during enteral nutrition in ICU patients: the REGANE study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23321763" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Effect of not monitoring residual gastric volume on risk of ventilator-associated pneumonia in adults receiving mechanical ventilation and early enteral feeding: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17387118" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21798809" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24687313" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27778318" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24663255" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33368159" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29744564" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34609548" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Effect of oral chlorhexidine de-adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi-center stepped wedge cluster-randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9554897" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18564793" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Impact of selective decontamination of the digestive tract on carriage and infection due to Gram-negative and Gram-positive bacteria: a systematic review of randomised controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25252684" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33481250" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Topical antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving mechanical ventilation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36286098" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19118302" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Decontamination of the digestive tract and oropharynx in ICU patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28418487" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Notice of Retraction and Replacement: Oostdijk et al. Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial. JAMA. 2014;312(14):1429-1437.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21148529" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Healthcare epidemiology: Ventilator-associated pneumonia: preventing the inevitable.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25271415" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Rational use of antibiotics in the ICU: balancing stewardship and clinical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30347072" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20185749" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Welkommen to our world. Emergence of antibiotic resistance with selective decontamination of the digestive tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19965807" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Ecological effects of selective decontamination on resistant gram-negative bacterial colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19965807" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Ecological effects of selective decontamination on resistant gram-negative bacterial colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20522788" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32127415" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-Analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34546300" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35608319" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Probiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18714060" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26266942" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Silver-coated endotracheal tubes for prevention of ventilator-associated pneumonia in critically ill patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37715208" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Prophylactic antibiotics for preventing ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37888914" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Inhaled Amikacin to Prevent Ventilator-Associated Pneumonia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20936973" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28759469" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : What is new in the prevention of nosocomial pneumonia in the ICU?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29023261" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Prevention of Ventilator-Associated Pneumonia: The Multimodal Approach of the Spanish ICU "Pneumonia Zero" Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21460481" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Collaborative cohort study of an intervention to reduce ventilator-associated pneumonia in the intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29629985" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Ventilator Bundle and Its Effects on Mortality Among ICU Patients: A Meta-Analysis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
